CincyTech
VC Fund
Cincinnati, United States
CincyTech is a VC fund in Cincinnati focused on Software and Health Care. CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions intoregional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.
- Total investments:
- 131
- Last investment:
- Lead investor:
- 53%
- Fund size:
- $2.8M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries CincyTech invests in
Stages CincyTech invests in
Countries CincyTech invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $250k–$3.9M
- Series A
- $300k–$20M
- Series B
- $2.5M–$11M
Investment Focus
Industry
- Software 20 (15%)
- Health Care 19 (15%)
- Biotechnology 11 (8%)
- Medical Device 11 (8%)
- Information Technology 11 (8%)
Stage
- Seed 43 (33%)
- Series A 29 (22%)
- Series B 14 (11%)
- Grant 5 (4%)
- Series C 4 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
John M. Rice
Managing Director
|
Managing Director | Total investments: 17 | Find email | |
Ashley Keating
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
Douglas Groh
DManaging Director
|
DManaging Director | Total investments: 1 | Find email | |
Emma Off
President
|
President | Total investments: 1 | Find email | |
Jamie Easterling
Executive in Residence
|
Executive in Residence | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ravee Optics is a satellite company that provides optical communications and ultracompact link solutions. | $6M / Seed / Jul 06, 2026 | ||
| TeamCentral is a company focused on optimizing productivity through improvements in how data is managed and governed across business systems. | $3.9M / Seed / May 27, 2025 | ||
| Invirsa is developing a unique, broad platform based on a naturally occurring small molecule (INV-102) that has demonstrated enhanced immune response to infection. INV-102 not only reduces viral infection, and potentially bacterial replication, it also reduces inflammation, while enhancing the bodies wound healing response. Invirsa'stechnology is first being developed in the ophthalmology and pulmonary space.Invirsa’s technology has the potential to be a first line therapy for common infectious diseases, whether it's the 100 million viral pulmonary infections or the 5 million infectious conjunctivitis cases that occur every year in the US alone. | $7.7M / Series B / Jun 14, 2023 | ||
| Voxel integrates advanced mathematics and artificial intelligence to build functionally graded meta-materials for high-performance applications. Voxel delivers performance leaps in defense, automotive, aerospace, medical, industrial, and other demanding domains, allowing customers to unlock new possibilities. | $1.7M / Seed / May 23, 2023 | ||
| Amify delivers turnkey, award-winning services to help brands launch, manage and continually optimize their Amazon channel strategy. As the first Amazon-as-a-Service provider, we serve as an outsourced Amazon team, which helps companies own their brand on the world’s largest ecommerce platform by leveraging cross channel data to increase sales andimprove customer experience. As of 2021, Amify is responsible for more than $200M of goods sold on Amazon, Amify transforms the platform into one of our client’s top two channels. The Amify team brings vast expertise to sellers from branding and advertising to data analytics and business operations. From our high-performing, beautiful storefronts, to our optimized forecasting and logistics, we’re an embedded extension of our client’s team, whose mission is to make it painless for clients to win on Amazon. | $4.2M / Series B / May 23, 2023 | ||
| Dev-first, fully-extensible managed Postgres. | $6.5M / Seed / Apr 17, 2023 | ||
| IncludeFitness provides an internationally awarded digital health platform that pairs HIPAA compliant cloud software with inclusive rehabilitation equipment to lower the barriers of maintaining physical health for all ages and abilities while optimizing the delivery of care. Its integrated software, The IFCloud, is the engine that provides profoundimprovements in provider efficacy and efficiency with features such as outcomes-based data collection, automated documentation, and cloud collaboration. Its inclusive functional trainer, The Access Strength, provides unprecedented versatility and ease-of-use for all demographics while capturing objective data through infusing universal design with technology. The platform is offered through a monthly subscription and provides better outcomes with higher quality and lower costs throughout the continuum of care.It was founded in 2009 and is headquartered in Cincinnati, Ohio. | $11M / Feb 16, 2023 | ||
| IncludeHealth partners with musculoskeletal providers to extend their reach beyond the clinic and unlock hybrid care models. Powered by computer vision, IncludeHealth's platform digitizes physical therapy and delivers personalized, measured care through patients' devices without needing additional hardware or downloads. Recognized withover 40 innovation and health awards, IncludeHealth's platform is utilized by health systems, physical therapy networks, orthopedic practices, and the government for remote therapeutic monitoring and value-based care. | $11M / Venture - Series Unknown / Feb 16, 2023 | ||
| Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened. | $17.5M / Series C / Oct 06, 2022 | ||
| XII Medical is a medical device developer company. It develops a minimally invasive outpatient technology for the treatment of obstructive sleep apnea. | $30M / Series A / May 05, 2022 | ||
| See all 131 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does CincyTech invest in?
CincyTech invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 131 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is CincyTech's check size?
CincyTech typically joins rounds of $250k–$3.9M at Seed, $300k–$20M at Series A and $2.5M–$11M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CincyTech participates in.
How do I contact CincyTech?
Public channels for CincyTech include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CincyTech?
The team at CincyTech includes John M. Rice (Managing Director), Ashley Keating (Chief Financial Officer) and Douglas Groh (DManaging Director), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
